lntervacc
About Us
Intervacc AB is a Swedish company within animal health developing safe, effective vaccines for animals. The Company's vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company´s research and development work. The Intervacc share has been listed on the Nasdaq First North Growth Market since April 2017.
Contacts
-
Jonas Sohlman
CEO
Box 112, S-129 22 Hägersten Visiting address: Västertorpsvägen 135, S-129
+46 (0) 70 576 30 73
https://www.intervacc.se
jonas.sohlman@intervacc.se